Found 30 matching trials
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
PHASE1The purpose of this study is to determine the safety and clinical efficacy ...
Location
Georgia Regents University
Panobinostat/Velcade in Multiple Myeloma
PHASE1Multiple myeloma (MM) accounts for approximately 1% of all malignancies and...
Location
Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences
CINC424A2X01B Rollover Protocol
PHASE4This is a long term safety study for patients that have been treated with e...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
PHASE1The purpose of this research study is to determine the amount of LBH589 tha...
Location
Northwestern University
Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
PHASE1This phase I trial studies the possible benefits and side effects of adding...
Location
Ohio State University Comprehensive Cancer Center
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
PHASE1The subjects are being asked to take part in the Phase I or Phase II portio...
Location
University of Pittsburgh
Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone
PHASE1This 2-arm study is designed to determine the maximum tolerated dose of LBH...
Location
Dana Farber Cancer Institute
Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
PHASE1The purpose of this study is to find out if panobinostat taken with cisplat...
Location
University of California Davis Cancer Center
Re-expression of ER in Triple Negative Breast Cancers
PHASE1Patients are being asked to take part in this study because they have metas...
Location
Emory University Winship Cancer Institute